Latin America Drug Screening Market

Latin America Drug Screening Market Size (2024 to 2029)

The size of the Latin American Drug Screening Market has been valued at USD 0.77 billion in 2024. It is expected to grow at a CAGR of 8.7% and be worth USD 1.17 billion by 2029.

Drug screening tests utilize biological samples such as saliva, blood, and hair to detect the presence of drugs or drugs’ metabolites in a person at a certain point in time. The rapid advancements in science and technology result in the invention of various new kinds of drug screening tests that provide better accuracy.

Factors such as the increase in alcohol consumption among young and old, the abuse of prescription drugs are the main drivers for the Latin America drug screening market. In 2018, Argentina had the highest alcohol consumption with 9.5 liters per person/ week followed closely by Chile in second place with 9.1 liters. The recent report also stated that Peru and Brazil are tied in the third position, having consumption of 9 liters. The intake of alcohol among females and adolescents has recently drastically increased by 14.1% and 18.9% respectively. Additionally, there is an increase in the use of narcotics and illicit drugs which are driving the Latin American drug screening market. According to the latest World Drug Report, over 352 million people had used drugs in 2019 and over 42 million people suffered from drug use disorders. Rising rates of drug use among adults and adolescents in developing countries has affected employment and economic standards. Collaboration and international takeovers are expected to reduce production costs for pharmaceutical companies to expand the market and further drive the growth of the LATAM drug screening market.

 In addition, high healthcare spending, favorable local initiatives are aiming for advancements in the fields of pharmacology and medicine, this has further stimulated the market growth.  Latest hi-tech products are employed for drug screening such as high throughput screening, spectroscopy, and bioinformatics for better drug identification. With drug addiction and alcohol consumption increasing at a rapid rate in the region, there is a demand for strict regulations and implementation in the region. Health authorities in many Latin American countries are focusing on implementing drug and alcohol testing measures, rising the alcohol consumption limit, and more funds for research and development which should boost demand for the studied market. Currently, there are several policies to develop and maintain a better marketing and distribution infrastructure in Argentina, this is aimed to encourage local and multinational players to enter into licensing and distribution agreements. Other Latin American countries are following the steps of Argentina, which will be responsible for driving the overall growth of the Latin America drug screening market.

However, certain factors such as restrictions on alcohol consumption on healthcare workers and athletes to maintain their work efficiency, lack of skilled labor for R & D, erratic economies in certain regions, limitations of international import of alcohol, are major concerns that could hamper the expansion of the Latin American drug screening market in the near future.

This research report on the Latin American Drug Screening Market has been segmented and sub-segmented into the following categories.

Latin America Drug Screening Market Analysis By Sample Type

• Hair

• Blood

• Urine

• Others

Latin America Drug Screening Market Analysis By End-user

• Hospitals

• Workplaces

• Criminal Justice

• Law Enforcement

Latin America Drug Screening Market Analysis By Products and Services

• Breathalyzers

• Rapid Test Device

• Immunoassay Analyser

• Chromatography

• Others

Latin America Drug Screening Market Analysis By Country

• Mexico

• Brazil

• Argentina

• Chile

• Rest of Latin America

The Latin America drug screening market is being dominated by Mexico with nearly 40% market share during the projected period. The market growth can be due to growing interest by pharmaceutical companies and harmful side effects on the overall economy. According to recent data, there has been an alarming increase in the number of deaths due to narcotic drugs used in Mexico in recent years. Therefore, pharmaceutical companies are turning to personalized medicine to address the alarming issue of addiction and withdrawal syndrome. This approach is expected to have a positive impact on the market in Mexico. In addition, along with the pharmaceutical companies, other sectors are also using high-throughput screening procedures to detect potential drugs, for instance in forensic sciences with the help of drug identification.

Argentina is expected to grow at a CAGR rate of 9.6% during the forecast period. Heavy drug and alcohol abuse, presence of a large population, consumption of illicit drugs, awareness of harmful effects of alcohol and drugs is anticipated to drive the LATAM drug screening market.

Prominent companies leading in the Latin American Drug Screening Market profiled in the report are Thermo Fisher Scientific Inc. Express Diagnostics Int’l Inc., Abbott Laboratories, Siemens AG, Alere Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Biorad Laboratories Inc., Shimadzu and Omega Laboratories.